Compare Baxter International Inc (BAX) vs Heron Therapeutics Inc (HRTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Baxter International Inc vs Heron Therapeutics Inc — how do they compare? Baxter International Inc trades at $27.61 (market cap $14.27B), while Heron Therapeutics Inc trades at $0.32 (market cap $61.47M). The key difference: Baxter International Inc is far larger — about 232.1× Heron Therapeutics Inc's market cap, and Baxter International Inc pays a 0.14% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| BAX | HRTX | |
|---|---|---|
Market Cap | $14.27B | $61.47M |
Sector | Health | Health |
52-Week High | $28.35 | $1.49 |
52-Week Low | $15.80 | $0.32 |
Enterprise Value | $21.79B | $168.21M |
Dividend Yield | 0.14% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Baxter International Inc
Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021. Legacy Baxter offers tools to help patients with acute and chronic kidney failure. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, and administrative sets.
Read more on BAX →About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →
